Skip to main content

Candriam S.C.A.

Position in LLY — ELI LILLY & Co

CIK 1537014 STRASSEN, N4

Position in LLY

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$383,803,465
-$95,787,575 QoQ
Shares Held
417,282
-6.5% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $1,534,786,576 across 9 Drug Manufacturers - General names. LLY ranks #1 (25.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
417,282 $383,803,465

All Filings in LLY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $383,803,465 417,282
2025-12-31 $479,591,040 446,264
2025-09-30 $351,050,196 460,092
2025-06-30 $359,213,660 460,808
2025-03-31 $397,142,126 480,854
2024-12-31 $404,691,664 524,212
2024-09-30 $448,196,160 505,899
2024-06-30 $439,667,013 485,616
2024-03-31 $319,381,364 410,537
2023-12-31 $220,059,295 377,512
2023-09-30 $169,766,918 316,063
2023-06-30 $159,132,885 339,317
2023-03-31 $166,355,051 484,407
2022-12-31 $196,773,994 537,869
2022-09-30 $177,507,185 548,963
2022-06-30 $155,860,278 480,709
2022-03-31 $169,090,602 590,462
2021-12-31 $144,238,216 522,186
2021-09-30 $31,780,234 137,547
2021-06-30 $27,953,470 121,791
2021-03-31 $37,501,312 200,735
2020-12-31 $33,892,097 200,735
2020-09-30 $37,123,712 250,802
2020-06-30 $47,615,976 290,023
2020-03-31 $41,453,004 298,825